Source: MassDevice

Implandata Ophthalmic: 'Breakthrough' eye-pressure sensor trial begins in Germany

Implandata Ophthalmic Products announced that the first patient in its international, multi-center, ARGOS-SC01 clinical study has been successfully implanted with its novel pressure sensor. This first-in-human clinical study is being conducted to validate the suprachoroidally placed Eyemate-SC, a sensor implant for continual monitoring of intraocular pressure (IOP). While Implandata's already CE-marked Eyemate-IO intraocular sensor implant [...]The post 'Breakthrough' eye-pressure sensor trial begins in Germany appeared first on MassDevice.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Max G. Ostermeier's photo - Co-Founder & CEO of Implandata Ophthalmic

Co-Founder & CEO

Max G. Ostermeier

CEO Approval Rating

79/100

Read more